Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Crame.

Yesterday, March 5, 2015, 90 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $198.00 to $6,023,498.68.

Highlighted Stocks Traded by Insiders:

Charles River Laboratories International In (CRL) - FREE Research Report

Chubb Stephen D, who is Director at Charles River Laboratories International In, sold 2,000 shares at $75.52 on March 5, 2015. Following this transaction, the Director owned 17,854 shares meaning that the stake was reduced by 10.07% with the 2,000-share transaction.

The shares most recently traded at $77.13, up $1.61, or 2.08% since the insider transaction. Historical insider transactions for Charles River Laboratories International In go as follows:

  • 4-Week # shares sold: 134,947
  • 12-Week # shares sold: 134,947
  • 24-Week # shares sold: 148,180

The average volume for Charles River Laboratories International In has been 398,400 shares per day over the past 30 days. Charles River Laboratories International In has a market cap of $3.6 billion and is part of the health care sector and health services industry. Shares are up 22.09% year-to-date as of the close of trading on Thursday.

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and preclinical development services worldwide. The company has a P/E ratio of 28.4. Currently, there are 6 analysts who rate Charles River Laboratories International In a buy, no analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRL - FREE

TheStreet Quant Ratings

rates Charles River Laboratories International In as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Charles River Laboratories International In Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Idacorp (IDA) - FREE Research Report

Carlile Thomas E, who is Director at Idacorp, bought 1,500 shares at $60.64 on March 5, 2015. Following this transaction, the Director owned 3,938 shares meaning that the stake was boosted by 61.52% with the 1,500-share transaction.

The shares most recently traded at $59.82, down $0.82, or 1.37% since the insider transaction. Historical insider transactions for Idacorp go as follows:

  • 4-Week # shares bought: 1,200
  • 4-Week # shares sold: 8,731
  • 12-Week # shares bought: 1,200
  • 12-Week # shares sold: 12,731
  • 24-Week # shares bought: 1,200
  • 24-Week # shares sold: 24,969

The average volume for Idacorp has been 260,400 shares per day over the past 30 days. Idacorp has a market cap of $3.1 billion and is part of the utilities sector and utilities industry. Shares are down 7.15% year-to-date as of the close of trading on Thursday.

IDACORP, Inc., through its subsidiary, Idaho Power Company, is engaged in the generation, transmission, distribution, purchase, and sale of electric energy in the United States. The stock currently has a dividend yield of 3.08%. The company has a P/E ratio of 15.8. Currently, there are no analysts who rate Idacorp a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IDA - FREE

TheStreet Quant Ratings

rates Idacorp as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, increase in net income, largely solid financial position with reasonable debt levels by most measures, notable return on equity and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Idacorp Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Watts Water Technologies (WTS) - FREE Research Report

Melhem Elie, who is President, Asia at Watts Water Technologies, sold 1,600 shares at $54.48 on March 5, 2015. Following this transaction, the President, Asia owned 18,551 shares meaning that the stake was reduced by 7.94% with the 1,600-share transaction.

The shares most recently traded at $54.31, down $0.17, or 0.31% since the insider transaction. Historical insider transactions for Watts Water Technologies go as follows:

  • 4-Week # shares sold: 997
  • 12-Week # shares sold: 997
  • 24-Week # shares sold: 997

The average volume for Watts Water Technologies has been 199,700 shares per day over the past 30 days. Watts Water Technologies has a market cap of $1.6 billion and is part of the industrial goods sector and industrial industry. Shares are down 14.27% year-to-date as of the close of trading on Thursday.

Watts Water Technologies, Inc. designs, manufactures, and sells various water safety and flow control products for the water quality, water conservation, water safety, and water flow control markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The stock currently has a dividend yield of 1.1%. The company has a P/E ratio of 38.5. Currently, there are 4 analysts who rate Watts Water Technologies a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WTS - FREE

TheStreet Quant Ratings

rates Watts Water Technologies as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Watts Water Technologies Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null